Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
Singapore · Delayed Price · Currency is SGD 0.0520
+0.0010 (1.96%)
At close: Feb 9, 2026
SGXC:9G2 Revenue
In the fiscal year ending June 30, 2025, Singapore Institute of Advanced Medicine Holdings had annual revenue of 15.71M SGD, down -5.63%. Singapore Institute of Advanced Medicine Holdings had revenue of 7.67M in the half year ending June 30, 2025.
Revenue
15.71M
Revenue Growth
-5.63%
P/S Ratio
4.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
62.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 15.71M | -936.78K | -5.63% |
| Jun 30, 2024 | 16.65M | 412.41K | 2.54% |
| Jun 30, 2023 | 16.23M | 2.43M | 17.56% |
| Jun 30, 2022 | 13.81M | 891.35K | 6.90% |
| Jun 30, 2021 | 12.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UG Healthcare Corporation | 144.07M |
| Kim Heng | 134.31M |
| Atlantic Navigation Holdings (Singapore) | 123.26M |
| ISOTeam | 119.21M |
| Zixin Group Holdings | 88.60M |
| Medtecs International Corporation | 83.19M |
| YKGI Limited | 67.36M |
| Goodwill Entertainment Holding | 54.25M |